MS: Funding acquisition, Resources, Supervision, Validation, Writing review & editing
If Lilly doesnt pull the ads voluntarily, Novo said it will ask the court to force Lilly to stop airing them, based on evidence that consumers are being confused and misled. Lilly contends that its campaign is using the results of a head-to-head trial, Surmount-5, showing that the lower, 2.4 milligram dose of Wegovy resulted in 47% lower relative weight loss than Zepbound
Rapid weight loss without adequate protein intake, resistance training, mobility work, and structured follow-up may increase the risk of lean tissue loss, tendon overload, frailty, and downstream musculoskeletal complications
Every effective retatrutide protocol includes a titration schedule, and the starting dose is simply the first step on that ladder